ALVOGEN GROUP HOLDINGS LLC v. BAYER PHARMA AG

10148, 653930/18.

176 A.D.3d 551 (2019)

110 N.Y.S.3d 668

2019 NY Slip Op 07533

Alvogen Group Holdings LLC et al., Appellants, v. Bayer Pharma AG et al., Respondents.

Appellate Division of the Supreme Court of New York, First Department.

Decided October 22, 2019.


Attorney(s) appearing for the Case

Baker Botts L.L.P., New York ( Earl B. Austin of counsel), for appellants.

Hughes Hubbard & Reed LLP, New York ( Robb W. Patryk of counsel), for respondents.

Concur—Acosta, P.J., Richter, Mazzarelli, Webber, Kern, JJ.


The first cause of action, seeking rescission of the Asset Sale and Purchase Agreement (APA), was correctly dismissed because section 9.10 of the APA states that, except in cases of fraud, willful misconduct, or intentional misrepresentation— which plaintiffs do not allege —"the indemnification provisions of this Article 9 shall be [plaintiffs'] sole and exclusive remedy... for all matters arising under or in connection with this Agreement and the Transaction...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases